Genetic susceptibility and regulation of inflammation on Crohn's disease. Relationship with the innate immune system

Revista Espanola de Enfermedades Digestivas

Volumn 94, Issue 6, 2002, Pages 356-360

  Pena A S ^a   Penate M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; CARD15 PROTEIN, HUMAN; CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CELL SURFACE RECEPTOR; DROSOPHILA PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; SIGNAL PEPTIDE; TOLL LIKE RECEPTOR;

ARTICLE; CHROMOSOME 16Q; CHRONIC DISEASE; CORRELATION ANALYSIS; CROHN DISEASE; ENTERITIS; FAMILIAL INCIDENCE; GASTROINTESTINAL DISEASE; GENE IDENTIFICATION; GENE INSERTION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; INFLAMMATION; INTESTINE FLORA; MEDICAL RESEARCH; MOLECULAR MODEL; MOLECULAR RECOGNITION; PATHOGENESIS; PROTEIN FUNCTION; TWINS; ULCERATIVE COLITIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; REVIEW;

CARRIER PROTEINS; CROHN DISEASE; DROSOPHILA PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE SYSTEM; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTORS;

EID: 0036328758     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Genetic epidemiology of inflammatory bowel disease
3. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
4. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis
5. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16
6. Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16
7. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
8. Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus-a GISC study
9. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
10. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations
11. Human Nod1 confers responsiveness to bacterial lipopolysaccharides
12. Relevance of the innate immune system
13. The NOD: A signaling module that regulates apoptosis and host defense against pathogens
14. Autoimmunity and apoptosis: The Crohn's connection
15. Toll-like receptors in the induction of the innate immune response
16. Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells
17. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
18. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
19. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
20. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
21. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice
22. Intestinal inflammation and the gut microflora
23. Activation of nuclear factor kappa B inflammatory bowel disease
24. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
25. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
26. NF-kappa B and inflammatory intestinal diseases
27. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
28. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease
29. The I kappa B kinase: A master regulator of NF-kappa B, innate immunity, and epidermal differentiation
30. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3
31. Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs
32. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9
33. A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death
34. NF-kappaB and the innate immune response
35. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3
36. Nitric oxide and inflammatory bowel disease
37. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis
38. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
39. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
40. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
41. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin
42. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway
43. Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells
44. 3020insC mutation within the NOD2 gene in Crohn's disease: Frequency and association with clinical pattern in an Italian population
45. CARD15 gene and the classification of Crohn's disease
46. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
47. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
48. The molecular classification of the clinical manifestations of Crohn's disease
49. Genes, microbes, and T cells-new therapeutic targets in Crohn's disease